New Insights into Target Organ Involvement in Hypertension

被引：2

作者：

Re, Richard N. ^{[1
]}

机构：

[1] Ochsner Clin Fdn, New Orleans, LA 70121 USA

来源：

MEDICAL CLINICS OF NORTH AMERICA | 2009年 / 93卷 / 03期

关键词：

Hypertension; Renin angiotensin system; Prorenin; Vascular disease; Intracrine; RENIN-ANGIOTENSIN SYSTEM; SMOOTH-MUSCLE-CELLS; INTRACRINE HORMONE ACTION; AT(1) RECEPTOR; INTRACELLULAR RENIN; (PRO)RENIN RECEPTOR; MEDIATED HYPERTENSION; ALDOSTERONE-SYSTEM; DIABETES-MELLITUS; CELLULAR BIOLOGY;

D O I：

10.1016/j.mcna.2009.02.009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Optimization of the care of the hypertensive patient will require not only attention to the regulation of arterial pressure but also to blunting the hypertension-related processes that lead to vascular disease. It is clear that the regulation of these processes is much more complex than previously understood. Here several new insights into the pathogenesis of hypertension-related vascular disease are explored with an emphasis on the role played by the renin-angiotensin systems.

引用

页码：559 / +

页数：10

共 50 条

[31] New insights into the treatment of hypertension
Tomlinson, B
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1997, 24 (12) : 978 - 981
[32] Mechanisms of target organ damage caused by hypertension: Therapeutic potential
Cohuet, G.
Struijker-Boudier, H.
PHARMACOLOGY & THERAPEUTICS, 2006, 111 (01) : 81 - 98
[33] Insights into the relationship between serum uric acid and pulmonary hypertension (Review)
Zhou, Yu
Chen, Meihong
Zheng, Jing
Shui, Xiaorong
He, Yuan
Luo, Hui
Lei, Wei
MOLECULAR MEDICINE REPORTS, 2024, 29 (01)
[34] Urotensin II and ghrelin and target organ damage in primary hypertension
Jolda-Mydlowska, Beata
Kobusiak-Prokopowicz, Malgorzata
Przewlocka-Kosmala, Monika
Witkowska, Maria
ARTERIAL HYPERTENSION, 2006, 10 (02): : 128 - 135
[35] Protective effect of nebivolol to prevent target organ damage in hypertension
Widecka, Krystyna
ARTERIAL HYPERTENSION, 2018, 22 (01): : 1 - 8
[36] Subtypes of masked hypertension and target organ damage in untreated outpatients
Zhang, Dong-Yan
Cheng, Yi-Bang
Guo, Qian-Hui
Wang, Ying
Sheng, Chang-Sheng
Huang, Qi-Fang
An, De-Wei
Li, Ming-Xuan
Huang, Jian-Feng
Xu, Ting-Yan
Wang, Ji-Guang
Li, Yan
BLOOD PRESSURE, 2020, 29 (05) : 299 - 307
[37] Target organ damage in hypertension: Pathophysiology and implications for drug therapy
Nadar, Sunil K.
Tayebjee, Muzahir H.
Messerli, Franz
Lip, Gregory Y. H.
CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (13) : 1581 - 1592
[38] Biomarkers in Hypertension and Their Relationship with Myocardial Target-Organ Damage
Xue, Yang
Iqbal, Navaid
Chan, Jeffrey
Maisel, Alan
CURRENT HYPERTENSION REPORTS, 2014, 16 (12) : 1 - 7
[39] Hypertension (Blood Pressure) and Lifetime Risk of Target Organ Damage
Jones, Daniel W.
Clark, Donald C., III
CURRENT HYPERTENSION REPORTS, 2020, 22 (10)
[40] Hypertension (Blood Pressure) and Lifetime Risk of Target Organ Damage
Daniel W. Jones
Donald C. Clark
Current Hypertension Reports, 2020, 22

← 1 2 3 4 5 →